🟢 90/100

This product looks safe

  • Total Omega-3 Fatty Acids: 3750mg is 1.2× the Tolerable Upper Intake Level (3000mg)
  • 25% of ingredients have research evidence
C Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Total Omega-3 Fatty Acids: 3750mg is 1.2× the Tolerable Upper Intake Level (3000mg)

Label Data

3 Softgel(s) Serving Size
100 Servings
Fat/Fatty Acid Product Type
25% Evidence Coverage

Supplement Facts — Evidence Check

Calories
20 Calorie(s)
Calories from Fat
20 Calorie(s)
Total Fat
3.75 Gram(s) (4% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 1.2× (UL: 3000 mg) 📚 388 studies (Tier A: 18, B: 204)
This product: 3750mg UL 3000mg

Other Ingredients

Gelatin Glycerin purified Water

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Directions: As a dietary supplement, take 3 softgels with meal daily. For best results, please consult your physician.

⚠️ Warnings & Precautions

Keep out of the reach of children.

If pregnant/lactating or taking any medications, please consult your physician prior to use.

🧪 Formulation Notes

2,000mg EPA + 1,500mg DHA

Supports cardiovascular health

Soy Non-GMO No gluten

Free of: soy, dairy, yeast, gluten, corn.

Additional Information

Keep in a cool, dry place.

Product Details

UPC / SKU X001Z2KPA3
DSLD Entry Date 2020-08-23
Product Type Fat/Fatty Acid
Form Softgel Capsule
DSLD ID 231854
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →